title: Umbilical cord blood T cells express multiple natural cytotoxicity receptors after IL-15 stimulation, but only NKp30 is functional.
abstract: The natural cytotoxicity receptors (NCRs) NKp30, NKp44, and NKp46 are thought to be NK lineage restricted. Herein we show that IL-15 induces NCR expression on umbilical cord blood (UCB) T cells. NCRs were mainly on CD8(+) and CD56(+) UCB T cells. Only NKp30 was functional as demonstrated by degranulation, IFN-gamma release, redirected killing, and apoptosis. Since NCRs require adaptor proteins for function, the expressions of these adaptors were determined. The adaptors used by NKp30 and NKp46, FcepsilonR1gamma and CD3zeta, were detected in UCB T cells. There was a near absence of DAP12, the adaptor for NKp44, consistent with a hypofunctional state. NKp46 was on significantly fewer UCB T cells, possibly accounting for its lack of function. Adult peripheral blood (PB) T cells showed minimal NCR acquisition after culture with IL-15. Since UCB contains a high frequency of naive T cells, purified naive T cells from adult PB were tested. Although NKp30 was expressed on a small fraction of naive PB T cells, it was nonfunctional. In contrast to UCB, PB T cells lacked FcepsilonR1gamma expression. These results demonstrate differences between UCB and PB T cells regarding NCR expression and function. Such findings challenge the concept that NCRs are NK cell specific.
authors.affiliation: Department of Pediatrics, Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
authors.forename: Qin
authors.initials: Q
authors.lastname: Tang
authors.forename: Bartosz
authors.initials: B
authors.lastname: Grzywacz
authors.forename: Hongbo
authors.initials: H
authors.lastname: Wang
authors.forename: Nandini
authors.initials: N
authors.lastname: Kataria
authors.forename: Qing
authors.initials: Q
authors.lastname: Cao
authors.forename: John E
authors.initials: JE
authors.lastname: Wagner
authors.forename: Bruce R
authors.initials: BR
authors.lastname: Blazar
authors.forename: Jeffrey S
authors.initials: JS
authors.lastname: Miller
authors.forename: Michael R
authors.initials: MR
authors.lastname: Verneris
mesh_terms: D000328:Adult; D000818:Animals; D017209:Apoptosis / Q000235:genetics / Q000276:immunology; D015550:Cell Degranulation / Q000235:genetics / Q000276:immunology; D045744:Cell Line, Tumor; D002469:Cell Separation; D002478:Cells, Cultured; D003601:Cytotoxicity Tests, Immunologic; D005312:Fetal Blood / Q000166:cytology* / Q000276:immunology* / Q000378:metabolism; D005786:Gene Expression Regulation / Q000276:immunology*; D006801:Humans; D007371:Interferon-gamma / Q000378:metabolism; D019409:Interleukin-15 / Q000502:physiology*; D008213:Lymphocyte Activation / Q000235:genetics / Q000276:immunology; D051379:Mice; D055628:Natural Cytotoxicity Triggering Receptor 3 / Q000096:biosynthesis / Q000097:blood* / Q000502:physiology; D055611:Natural Killer T-Cells / Q000276:immunology* / Q000378:metabolism
chemical_list: D019409:Interleukin-15; C431710:NCR3 protein, human; D055628:Natural Cytotoxicity Triggering Receptor 3; D007371:Interferon-gamma
references.citation: Blood. 1999 Nov 1;94(9):3101-7
references.pmid: 10556195
references.citation: Science. 1995 Apr 21;268(5209):403-5
references.pmid: 7716542
references.citation: J Immunol. 2000 Feb 1;164(3):1148-52
references.pmid: 10640724
references.citation: J Immunol. 2000 Jul 15;165(2):1138-45
references.pmid: 10878393
references.citation: Eur J Immunol. 2000 Jun;30(6):1665-75
references.pmid: 10898503
references.citation: Br J Haematol. 1995 Apr;89(4):733-40
references.pmid: 7772509
references.citation: J Exp Med. 1997 Oct 6;186(7):1129-36
references.pmid: 9314561
references.citation: Proc Natl Acad Sci U S A. 1998 Feb 3;95(3):1172-7
references.pmid: 9448304
references.citation: J Exp Med. 1998 Jun 15;187(12):2065-72
references.pmid: 9625766
references.citation: Blood. 1998 Jul 1;92(1):11-8
references.pmid: 9639493
references.citation: Clin Exp Immunol. 1998 Aug;113(2):220-8
references.pmid: 9717971
references.citation: J Exp Med. 1998 Sep 7;188(5):953-60
references.pmid: 9730896
references.citation: J Exp Med. 1999 Mar 1;189(5):787-96
references.pmid: 10049942
references.citation: J Immunol. 1999 Apr 15;162(8):4464-71
references.pmid: 10201983
references.citation: Eur J Immunol. 1999 May;29(5):1656-66
references.pmid: 10359120
references.citation: Eur J Immunol. 2004 Dec;34(12):3456-64
references.pmid: 15517612
references.citation: Eur J Immunol. 2004 Dec;34(12):3413-22
references.pmid: 15549734
references.citation: Blood. 2005 Feb 15;105(4):1823-7
references.pmid: 15498856
references.citation: J Immunol. 2005 Mar 1;174(5):2653-60
references.pmid: 15728472
references.citation: J Clin Oncol. 2005 Apr 1;23(10):2346-57
references.pmid: 15800326
references.citation: Blood. 2005 Apr 15;105(8):3051-7
references.pmid: 15632206
references.citation: Eur J Immunol. 2005 Jul;35(7):2071-80
references.pmid: 15940674
references.citation: J Virol. 2006 Mar;80(5):2225-33
references.pmid: 16474130
references.citation: Blood. 2006 Apr 1;107(7):2643-52
references.pmid: 16352804
references.citation: J Exp Med. 2006 May 15;203(5):1343-55
references.pmid: 16682498
references.citation: J Leukoc Biol. 2006 Jun;79(6):1252-9
references.pmid: 16574769
references.citation: J Infect Dis. 2007 Apr 15;195(8):1160-8
references.pmid: 17357052
references.citation: Cell Microbiol. 2007 Apr;9(4):962-76
references.pmid: 17381429
references.citation: Nat Immunol. 2001 Mar;2(3):255-60
references.pmid: 11224526
references.citation: Nat Immunol. 2001 May;2(5):430-5
references.pmid: 11323697
references.citation: Exp Hematol. 2001 Jul;29(7):903-9
references.pmid: 11438213
references.citation: J Immunol. 2001 Nov 15;167(10):5527-30
references.pmid: 11698420
references.citation: Tissue Antigens. 2001 Oct;58(4):255-8
references.pmid: 11782277
references.citation: Nat Immunol. 2002 Feb;3(2):189-95
references.pmid: 11812997
references.citation: Blood. 2002 Sep 15;100(6):2153-8
references.pmid: 12200380
references.citation: Immunity. 2002 Oct;17(4):487-99
references.pmid: 12387742
references.citation: J Immunol. 2002 Nov 15;169(10):5382-6
references.pmid: 12421909
references.citation: J Exp Med. 2003 Feb 17;197(4):437-49
references.pmid: 12591902
references.citation: Eur J Immunol. 2003 May;33(5):1235-41
references.pmid: 12731048
references.citation: Nat Rev Cancer. 2003 Jul;3(7):526-32
references.pmid: 12835672
references.citation: Nat Immunol. 2003 Sep;4(9):835-42
references.pmid: 12942084
references.citation: Blood. 2003 Sep 15;102(6):2195-7
references.pmid: 12763931
references.citation: Annu Rev Immunol. 2001;19:197-223
references.pmid: 11244035
references.citation: Nat Med. 2003 Nov;9(11):1377-82
references.pmid: 14528297
references.citation: Blood. 2003 Dec 15;102(13):4608-17
references.pmid: 12946996
references.citation: J Clin Immunol. 2003 Nov;23(6):485-97
references.pmid: 15031636
references.citation: Blood. 2004 Apr 15;103(8):3065-72
references.pmid: 15070686
references.citation: Immunity. 2004 Sep;21(3):357-66
references.pmid: 15357947
references.citation: Am J Obstet Gynecol. 1992 Oct;167(4 Pt 1):895-900
references.pmid: 1415422
references.citation: J Immunol. 1994 Aug 15;153(4):1687-96
references.pmid: 7519209
references.citation: J Exp Med. 1994 Aug 1;180(2):673-9
references.pmid: 8046340
references.citation: J Exp Med. 1995 Jan 1;181(1):71-7
references.pmid: 7528780
references.citation: Blood. 1995 Mar 15;85(6):1540-6
references.pmid: 7534135
references.citation: Pediatr Res. 1995 Jan;37(1):64-9
references.pmid: 7700735
references.citation: J Exp Med. 1999 Nov 15;190(10):1505-16
references.pmid: 10562324